Credit: Recor Medical. The approval was based on data from the RADIANCE II trial which included patient with mild to moderate hypertension who were adequately controlled with medications. The Food and ...
This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...
A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...
The Paradise ultrasound renal denervation system got backing from the FDA's Circulatory System Devices Panel as a possible treatment for hypertension, as manufacturer ReCor continues to hope for ...
The US Food and Drug Administration has approved the Symplicity Spyral renal denervation system despite the lack of an endorsement from one of its advisory committees, bringing a second such ...
Advisors on the US Food and Drug Administration’s Circulatory System Devices Panel voted today in support of the premarket approval (PMA) application for the Paradise Ultrasound Renal Denervation ...
For the first time in its history, the U.S. Renal Data System Annual Data Report included a chapter devoted to home dialysis, offering an unprecedented view of the evolution of home therapies during ...
WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first-in-human cases ...
A link exists between the two, but more research is needed to figure out why and how to treat urinary incontinence related to COVID-19. COVID-19 tends to affect the respiratory system. But research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback